ZEAL - Zealand Pharma A/S. - ADR
Close
17.59
0.210 1.194%
Share volume: 0
Last Updated: Thu 29 Sep 2022 10:00:00 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$17.38
0.21
1.21%
Summary score
12%
Profitability
0%
Dept financing
6%
Liquidity
73%
Performance
10%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-9.31%
Return on assets
-9.4%
Return on sales
-512.36%
Return on invested capital
-144.96%
Total debt ratio
30.81%
Debt ratio change over timeo
-0.79%
Current Ratio
7.24%
Quick Ratio
6.51%
Cash Position Ratio
5.8%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-10.39%
Return on assets
-8.24%
Return on sales
-668.19%
Return on invested capital
-950.29%
Total debt ratio
20.75%
Debt ratio change over timeo
-0.84%
Current Ratio
6.64%
Quick Ratio
6.51%
Cash Position Ratio
4.91%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-3.17%
Return on assets
-2.35%
Return on sales
-24.64%
Return on invested capital
-147.36%
Total debt ratio
20.77%
Debt ratio change over time
-1%
Current Ratio
6.76%
Quick Ratio
6.51%
Cash Position Ratio
4.69%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-123.5%
Return on assets
-112.39%
Return on sales
-850.31%
Return on invested capital
42.09%
Total debt ratio
-78.91%
Debt ratio change over time
-0.79%
Current Ratio
3.95%
Quick Ratio
-1.14%
Cash Position Ratio
3.1%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ZEAL | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -9.31% | 0% | 0% | 29.06% |
| Return on assets | -9.4% | 0% | 0% | -9.75% |
| Return on sales | -512.36% | 0% | 0% | -1469.44% |
| Return on invested capital | -144.96% | 0% | 0% | 47.78% |
| Profitability | 0% | 0% | 50% | 50% |
| Total debt ratio | 30.81% | 0% | 0% | 183.15% |
| Debt ratio change over time | -0.79% | 0% | 0% | 19.02% |
| Dept financing | 4% | 0% | 0% | 50% |
| Current Ratio | 6.64% | 0% | 0% | 5.9% |
| Quick Ratio | 6.51% | 0% | 0% | 5.9% |
| Cash Position Ratio | 4.91% | 0% | 0% | 5.68% |
| Liquididy | 75% | 0% | 0% | 49% |
| Short-term ratios | ZEAL | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -10.39% | 0% | 0% | -16.12% |
| Return on assets | -8.24% | 0% | 0% | -14.95% |
| Return on sales | -668.19% | 0% | 0% | -3498.94% |
| Return on invested capital | -950.29% | 0% | 0% | 96.56% |
| Profitability | 0% | 0% | 75% | 25% |
| Total debt ratio | 20.75% | 0% | 0% | 79.61% |
| Debt ratio change over time | -0.84% | 0% | 0% | 0.09% |
| Dept financing | 7% | 0% | 0% | 50% |
| Current Ratio | 6.64% | 0% | 0% | 5.9% |
| Quick Ratio | 6.51% | 0% | 0% | 5.9% |
| Cash Position Ratio | 4.91% | 0% | 0% | 5.68% |
| Liquididy | 72% | 0% | 0% | 70% |